Bruker (BRKR) - Get Report was downgraded to market perform at Wells Fargo. Earnings estimates were also reduced as growth visibility remains poor, Wells said.
Endologix (ELGX) - Get Report was downgraded to sector perform at RBC Capital. $12 price target. Potential Nellix approval will likely be pushed out until the fourth quarter of 2017, RBC said.
Loew's (L) - Get Report was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: L.
Mosaic (MOS) - Get Report was downgraded to underperform from neutral at Credit Suisse. $21 price target. Earnings estimates were also cut, given continued commodity headwinds, Credit Suisse said.
QEP Resources (QEP) - Get Report was upgraded to overweight at Barclays. $22 price target. Pivot to the Permian and Williston basins should boost growth and returns, Barclays said.
Trex (TREX) - Get Report was downgraded to neutral from outperform at Wedbush. $53 price target. The valuation is less attractive, as the stock is up nearly 50% year-to-date, Wedbush said.
This article was written by a staff member of TheStreet.